(Reuters) -AbbVie on Thursday cut its 2025 adjusted profit forecast as the drugmaker expects to incur $248 million in acquisition-related expenses. The company expects adjusted profit in the range of ...

In a regulatory filing, AbbVie (ABBV) disclosed that reported GAAP earnings and adjusted non-GAAP earnings for the first quarter of 2025 are ...

In a report released yesterday, Courtney Breen from Bernstein maintained a Hold rating on AbbVie (ABBV – Research Report), with a price target ...

Hull, United Kingdom 2024 New York Stock Exchange 2024 500+ sites will spark blue PD Avengers - Global Alliance to End Parkin ...

That included active ingredients for popular medicines such as Botox made by Abbvie, weight-loss drugs Wegovy and Zepbound from Novo Nordisk and Eli Lilly and Keytruda for cancer by Merck. Ireland - a ...

NEW YORK (Reuters) -Large deals involving pharmaceutical and biotech companies are stalling as executives grapple with ...

The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a ...

The current US Commerce Secretary - Howard Luttnick - has once again targeted Ireland, calling our country his 'favourite tax ...

Investors with a lot of money to spend have taken a bullish stance on AbbVie ABBV. And retail traders should know. We noticed this today when the trades showed up on publicly available options ...

AbbVie’s former CEO Richard Gonzalez—who collected a $25.7 million payout for his final full year on the job in 2023—often ranked among the industry’s highest-paid CEOs during his tenure ...